BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21166501)

  • 1. Association between NFKB1 -94ins/delATTG promoter polymorphism and cancer risk: a meta-analysis.
    Zou YF; Yuan FL; Feng XL; Tao JH; Ding N; Pan FM; Wang F
    Cancer Invest; 2011 Jan; 29(1):78-85. PubMed ID: 21166501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of NFKB1 -94ins/delATTG promoter polymorphism with susceptibility to autoimmune and inflammatory diseases: a meta-analysis.
    Zou YF; Wang F; Feng XL; Tao JH; Zhu JM; Pan FM; Su H
    Tissue Antigens; 2011 Jan; 77(1):9-17. PubMed ID: 21155719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NFKB1 -94insertion/deletion ATTG polymorphism and cancer risk: Evidence from 50 case-control studies.
    Fu W; Zhuo ZJ; Chen YC; Zhu J; Zhao Z; Jia W; Hu JH; Fu K; Zhu SB; He J; Liu GC
    Oncotarget; 2017 Feb; 8(6):9806-9822. PubMed ID: 28039461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of association of a functional -94ins/delATTG NFKB1 promoter polymorphism with susceptibility and clinical expression of biopsy-proven giant cell arteritis in northwest Spain.
    Martin J; Perez-Armengol C; Miranda-Filloy JA; Vilchez JR; Lopez-Nevot MA; Garcia-Porrua C; Gonzalez-Gay MA
    J Rheumatol; 2006 Feb; 33(2):285-8. PubMed ID: 16465659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NFKB1 promoter -94 insertion/deletion ATTG polymorphism (rs28362491) is associated with severity and disease progression of rheumatoid arthritis through interleukin-6 levels modulation in Egyptian patients.
    Elkhawaga SY; Gomaa MH; Elsayed MM; Ebeed AA
    Clin Rheumatol; 2021 Jul; 40(7):2927-2937. PubMed ID: 33459954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between the NFKB1-94ins/del ATTG polymorphism and cancer risk: an updated meta-analysis.
    Duan W; Wang E; Zhang F; Wang T; You X; Qiao B
    Cancer Invest; 2014 Aug; 32(7):311-20. PubMed ID: 24827594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional polymorphism of the NFKB1 gene promoter is not relevant in predisposition to celiac disease.
    Rueda B; Núñez C; López-Nevot MA; Paz Ruiz M; Urcelay E; De la Concha EG; Martín J
    Scand J Gastroenterol; 2006 Apr; 41(4):420-3. PubMed ID: 16635909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An updated meta-analysis of 37 case-control studies on the association between NFKB1 -94ins/del ATTG promoter polymorphism and cancer susceptibility.
    Luo YQ; Wang D; Gong T; Zhu J
    Oncotarget; 2016 Sep; 7(36):58659-58670. PubMed ID: 27463002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between obesity and the NFKB1 - 94ins/delATTG promoter polymorphism in relation to incident acute coronary syndrome: a follow up study in three independent cohorts.
    Stegger JG; Schmidt EB; Berentzen TL; Tjønneland A; Vogel U; Rimm E; Sørensen TI; Overvad K; Jensen MK
    PLoS One; 2013; 8(5):e63004. PubMed ID: 23671649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of studies on the association between the NF-κB1-94ins/del ATTG promoter polymorphism and cancer.
    Nian X; Zhang W; Li L; Sun Y; Sun E; Han R
    Tumour Biol; 2014 Dec; 35(12):11921-31. PubMed ID: 25190017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the NFKB1 -94ins/delATTG promoter polymorphism in IBD and potential interactions with polymorphisms in the CARD15/NOD2, IKBL, and IL-1RN genes.
    Glas J; Török HP; Tonenchi L; Müller-Myhsok B; Mussack T; Wetzke M; Klein W; Epplen JT; Griga T; Schiemann U; Lohse P; Seiderer J; Schnitzler F; Brand S; Ochsenkühn T; Folwaczny M; Folwaczny C
    Inflamm Bowel Dis; 2006 Jul; 12(7):606-11. PubMed ID: 16804398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contributions of NFKB1 -94insertion/deletion ATTG polymorphism to the susceptibility of gastrointestinal cancers: A meta-analysis.
    Wu H; Liang J
    J Cell Mol Med; 2021 Nov; 25(22):10674-10683. PubMed ID: 34672421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IS -94INS/DELATTG POLYMORPHISM IN THE NUCLEAR FACTOR KAPPA-B1 GENE (NFKB1) ASSOCIATED WITH NECROTIZING ENTEROCOLITIS?
    Ferdinando DLT; Fraga FDCB; Piatto VB; Souza AS
    Arq Bras Cir Dig; 2023; 35():e1717. PubMed ID: 36629694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the functional NFKB1 promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus.
    Orozco G; Sánchez E; Collado MD; López-Nevot MA; Paco L; García A; Jiménez-Alonso J; Martín J
    Tissue Antigens; 2005 Feb; 65(2):183-6. PubMed ID: 15713218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk association between the NF-κB1 -94ins/delATTG promoter polymorphism and inflammatory bowel diseases: a meta-analysis.
    Liang M; Xu X; Gong Y; Tang Y; Lin L
    Dig Dis Sci; 2012 Sep; 57(9):2304-9. PubMed ID: 22828805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NFKB1 promoter polymorphism: A new predictive marker of cytomegalovirus infection after kidney transplantation.
    Leone F; Gigliotti P; La Russa A; Lofaro D; Perri A; Vizza D; Lupinacci S; Toteda G; Bonofiglio M; Presta P; Talarico R; Aquino B; Bonofiglio R
    Transpl Infect Dis; 2019 Feb; 21(1):e13027. PubMed ID: 30431214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A functional polymorphism of the NFKB1 promoter is not associated with ulcerative colitis in a Spanish population.
    Oliver J; Gómez-García M; Paco L; López-Nevot MA; Piñero A; Correro F; Martín L; Brieva JA; Nieto A; Martín J
    Inflamm Bowel Dis; 2005 Jun; 11(6):576-9. PubMed ID: 15905705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between the NFKB1-94ins/del ATTG Polymorphism (rs28362491) and Coronary Artery Disease: A Systematic Review and Meta-Analysis.
    Chen QJ; Lai HM; Zhao L; Ma YT; Li XM; Zhai H; Zhou Y; He CH; Chen BD; Liu F; Yang YN
    Genet Test Mol Biomarkers; 2016 Mar; 20(3):105-11. PubMed ID: 26799199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of NFKB1 -94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' disease.
    Kurylowicz A; Hiromatsu Y; Jurecka-Lubieniecka B; Kula D; Kowalska M; Ichimura M; Koga H; Kaku H; Bar-Andziak E; Nauman J; Jarzab B; Ploski R; Bednarczuk T
    Genes Immun; 2007 Oct; 8(7):532-8. PubMed ID: 17690684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between glutathione S-transferase M1, P1, and NFKB1 polymorphisms and systemic lupus erythematosus susceptibility: a meta-analysis.
    Lee YH; Song GG
    Cell Mol Biol (Noisy-le-grand); 2016 Sep; 62(11):21-26. PubMed ID: 27755947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.